このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Medibank Private 将来の成長

Future 基準チェック /46

Medibank Private利益と収益がそれぞれ年間30.9%と4.8%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に25% 7.5%なると予測されています。

主要情報

28.1%

収益成長率

28.8%

EPS成長率

Insurance 収益成長	8.1%
収益成長率	4.5%
将来の株主資本利益率	24.5%
アナリストカバレッジ	Good
最終更新日	27 Sep 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

CHIA:MPL - アナリストの将来予測と過去の財務データ ( )AUD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
6/30/2027	9,334	650	646	724	4
6/30/2026	8,871	623	646	715	6
6/30/2025	8,595	587	656	671	5
6/30/2024	8,030	4	811	869	N/A
3/31/2024	7,939	89	N/A	N/A	N/A
12/31/2023	7,944	685	326	373	N/A
9/30/2023	7,720	598	234	279	N/A
6/30/2023	7,398	N/A	143	185	N/A
3/31/2023	7,261	171	N/A	N/A	N/A
12/31/2022	7,124	343	729	764	N/A
9/30/2022	7,114	368	821	856	N/A
6/30/2022	7,105	394	913	949	N/A
3/31/2022	7,117	414	693	728	N/A
12/31/2021	7,130	435	472	508	N/A
9/30/2021	7,081	438	460	495	N/A
6/30/2021	7,032	441	447	482	N/A
3/31/2021	6,930	402	547	579	N/A
12/31/2020	6,829	363	647	676	N/A
9/30/2020	6,804	340	595	624	N/A
6/30/2020	6,779	316	543	572	N/A
3/31/2020	6,836	368	451	486	N/A
12/31/2019	6,892	420	358	399	N/A
9/30/2019	6,829	429	362	408	N/A
6/30/2019	6,765	438	367	416	N/A
12/31/2018	6,381	375	332	377	N/A
9/30/2018	6,479	400	348	393	N/A
6/30/2018	6,577	424	365	408	N/A
3/31/2018	7,010	454	N/A	428	N/A
12/31/2017	7,006	463	N/A	448	N/A
9/30/2017	6,977	456	N/A	421	N/A
6/30/2017	6,948	450	N/A	393	N/A
3/31/2017	6,914	436	N/A	379	N/A
12/31/2016	6,879	422	N/A	365	N/A
9/30/2016	6,843	420	N/A	359	N/A
6/30/2016	6,807	418	N/A	352	N/A
3/31/2016	6,791	393	N/A	363	N/A
12/31/2015	6,774	369	N/A	374	N/A
9/30/2015	6,728	327	N/A	375	N/A
6/30/2015	6,682	285	N/A	377	N/A
3/31/2015	6,631	244	N/A	338	N/A
12/31/2014	6,581	204	N/A	298	N/A
9/30/2014	6,533	167	N/A	306	N/A
6/30/2014	6,486	131	N/A	313	N/A

アナリストによる今後の成長予測

収入対貯蓄率: MPLの予測収益成長率 (年間30.9% ) は貯蓄率 ( 2.4% ) を上回っています。

収益対市場: MPLの収益 ( 30.9% ) はAustralian市場 ( 13.3% ) よりも速いペースで成長すると予測されています。

高成長収益: MPLの収益は今後 3 年間で大幅に増加すると予想されています。

収益対市場: MPLの収益 ( 3.5% ) Australian市場 ( 5.4% ) よりも低い成長が予測されています。

高い収益成長: MPLの収益 ( 3.5% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: MPLの自己資本利益率は、3年後には高くなると予測されています ( 24 %)

Medibank Private 将来の成長

Future 基準チェック /46

主要情報

今後の成長に関する最新情報

Medibank Private Limited Provides Earnings Guidance for 2022

Recent updates

Medibank Private Limited, Annual General Meeting, Nov 13, 2024

Final dividend of AU$0.094 announced

Medibank Private Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on September 26, 2024

New minor risk - Profit margin trend

High number of new directors

First half dividend increased to AU$0.072

First half 2024 earnings released: EPS: AU$0.13 (vs AU$0.061 in 1H 2023)

New major risk - Revenue and earnings growth

Medibank Private Limited to Report First Half, 2024 Results on Feb 22, 2024

Medibank Private Limited Announces Changes to Executive Leadership Team

Anna Bligh to Retire as Non-Executive Director of Medibank Private Limited At the Conclusion its Annual General Meeting on 22 November 2023

Upcoming dividend of AU$0.083 per share at 4.1% yield

Medibank Private Limited Fully Franked Final Ordinary Dividend for the Six Months Ended 30 June 2023, Payable on 5 October 2023

Full year 2023 earnings released: EPS: AU$0.19 (vs AU$0.14 in FY 2022)

Medibank Private Limited Announces Executive Changes, Effective 31 July 2023

Medibank Private Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

First half 2023 earnings released: EPS: AU$0.085 (vs AU$0.08 in 1H 2022)

Medibank Announces Class Action Filed in the Federal Court of Australia

Medibank Private Limited to Report First Half, 2023 Results on Feb 23, 2023

Now 21% undervalued after recent price drop

Investor sentiment deteriorated over the past week

Upcoming dividend of AU$0.073 per share

Full year 2022 earnings released: EPS: AU$0.14 (vs AU$0.16 in FY 2021)

Medibank Private Limited Announces Distribution for the Six Months Ended June 30, 2022, Payable on September 29, 2022

Healius Reportedly Launches Day Surgery Sale Process

Medibank Private Limited to Report Fiscal Year 2022 Results on Aug 18, 2022

Independent Non-Executive Director recently bought AU$151k worth of stock

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Medibank Private Limited Announces Ordinary Fully Paid Dividend for the Six Months Ended December 31, 2021, Payable on March 24, 2022

Medibank Private Limited Appoints Kathryn Fagg Ao and Peter Everingham as Non-Executive Directors Effective 31 March 2022

Upcoming dividend of AU$0.069 per share

Full year 2021 earnings released: EPS AU$0.16 (vs AU$0.12 in FY 2020)

Medibank Private Limited Provides Earnings Guidance for 2022

CEO & Director Craig Drummond has left the company

Craig Drummond to Retire as Chief Executive Officer of Medibank Private Limited on 30 June 2021

New 90-day low: AU$2.83

Medibank Private Limited (ASX:MPL) entered into share purchase agreement to acquire 49%stake in Myhealth Medical Holdings Pty Ltd from Crescent Capital Partners Management Pty Ltd and others for AUD 63 million.

Medibank Private Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: AU$3.06

New 90-day high: AU$2.91

New 90-day low - AU$2.49

Independent Non-Executive Director recently bought AU$115k worth of stock

New 90-day low - AU$2.74

Earnings released

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘